Quick Guide: Cutimed® Sorbact® and antimicrobial stewardship

Share this article

Quick Guide: Cutimed® Sorbact® and antimicrobial stewardship

Supported by Essity
30 March 2022

Dressings that manage bacteria bioburden in wounds with a physical mode of action (e.g. Sorbact Technology) play an important role in an AMS-focused approach to wound care. These dressings can be used on any wound where infection control is needed — e.g. infected wounds or wounds at risk of infection (‘dirty’ or colonised wounds, or for patients with high risk of infection).

Cutimed® Sorbact® and Leukomed® Sorbact® dressings use simple physical principles to effectively bind bacteria and fungi. This means that they do not rely on killing bacteria with antimicrobial agents that may cause resistance. The bacteria are bound to the dressing surface, reducing bacterial load with every dressing change and helping to create optimum conditions for the natural wound healing process.

​Dressings with Sorbact Technology can be used on wounds of any aetiology and their physical mode of action means there is no cytotoxicity or contraindications (please refer to individual IFUs for exact guidance).

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.